Form 4 for NGVT Ingevity Corp

Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001902378-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-03-02	2026-02-26	NGVT	White Richard Allen JR	SVP, Pres, Perf Chemicals	A - Grant	$18.56	+774	22.4K	+4%	+$14.4K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-26	A	D	430	$70.52	22,020	D	—	—	(F3) Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 26, 2026.
2	Common	Common Stock	2026-02-26	A	A	1,204	$0.00	22,450	D	—	—	(F1) The Talent and Compensation Committee of the Company's board of directors certified the attainment of performance goals for certain performance-based restricted stock awards ("PSUs") effective February 26, 2026. The PSUs were settled with shares of common stock. (F2) Includes (i) 94 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP") for the purchase period of July 1, 2025 to September 30, 2025 (the "September ESPP Shares"), and (ii) 76 shares of Common Stock purchased pursuant to the ESPP for the purchase period of October 1, 2025 to December 31, 2025 (the "December ESPP Shares"). In accordance with the terms of the ESPP, the September ESPP Shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on July 1, 2025 and the December ESPP Shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on October 1, 2025.